Contextlogic Inc (LOGC NASDAQ) stock market data APIs
$7.76
-0.23(-2.9%)
as of February 4, 2025
Contextlogic Inc Financial Data Overview
ContextLogic Inc. does not have significant operations. It focuses on identifying, evaluating, and executing strategic opportunities. Previously, it was engaged in the marketplace and logistics business operations. ContextLogic Inc. was incorporated in 2010 and is headquartered in Oakland, California.
Prev. Close
7.76
Open
7.76
High
8.45
Low
8.09
52 wk Range
4.338-8.24
Market Cap
210 M
Shares Outstanding
26 285 K
Revenue
96 000 K
EPS
-0.04
Beta
2.055
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Contextlogic Inc data using free add-ons & libraries
Get Contextlogic Inc Fundamental Data
Contextlogic Inc Fundamental data includes:
- Net Revenue: 96 000 K
- EBITDA: -131 000 000
- Earnings Per Share: -5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-05
- EPS/Forecast: -0.01
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Contextlogic Inc News
New
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain
As per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033. Visiongain has pub...
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Condit...
Rare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports Ltd
Visiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Conditi...
Alexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® Therapeutics
LogicBio acquisition to build on current collaborations and advancements in genomic medicine WILMINGTON, Del., November 16, 2022--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease, today announced t...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
